Olivier Loeillot

Olivier Loeillot

President at REPLIGEN CORPORATION

Net worth: 3 M $ as of 31/03/2024

54 year
Health Technology
Finance
Commercial Services

Profile

Olivier Dominique Loeillot is currently the Director at Puridify Ltd.
and the President & Chief Commercial Officer at Repligen Corp.
He was previously the Chief Executive Officer at Ascensus Specialties LLC, Director at Cytiva Bioscience Holding Ltd., Management Partner at New Mountain Capital LLC, VP Sales LONZA at Lonza AG, and Senior Vice President Bioprocess Division at GE Healthcare CTH Holding Ltd.
He also worked as a Sales Director at Rhodia Pharma Solutions Ltd.
Mr. Loeillot holds an MBA from Emlyon Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/02/2024 15,786 ( 0.03% ) 3 M $ 31/03/2024

Olivier Loeillot active positions

CompaniesPositionStart
REPLIGEN CORPORATION President 02/10/2023
Director/Board Member 24/11/2017
All active positions of Olivier Loeillot

Former positions of Olivier Loeillot

CompaniesPositionEnd
Chief Executive Officer 01/06/2023
Director/Board Member 01/09/2022
Corporate Officer/Principal 01/04/2020
Sales & Marketing 01/09/2010
Private Equity Investor 01/06/2003
See the detail of Olivier Loeillot's experience

Training of Olivier Loeillot

Emlyon Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Olivier Loeillot's experience

Connections

28

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
REPLIGEN CORPORATION

Health Technology

Private companies7

Finance

Health Technology

Health Technology

Commercial Services

Process Industries

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Olivier Loeillot
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW